Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Total Debt

Short-term and long-term borrowings combined.

No reported Total Debt figures are available to summarize.

Total Debt history

Currency unavailable · from the balance sheet

No Total Debt data reported for this period type.

Total Debt vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Total Debt for ODTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ANABAnaptysBio, Inc.Mar 2026$277.36M USD+1680.8%-10.1%84.1%
ALMSAlumis Inc. Common StockJun 2026$36.43M USD-6.1%+174.8%6.5%
PTGXProtagonist Therapeutics, Inc.Jun 2026$9.22M USD-18.3%+41.3%1.0%
ORKAOruka Therapeutics, Inc.Sep 2026$2.93M USD+53.3%+71.5%0.2%
ACRSAclaris Therapeutics, Inc.Mar 2026$1.99M USD-20.1%+45.7%1.0%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€1.33M EUR——0.8%
IMUXImmunic, Inc.Mar 2026$421K USD-56.8%-24.1%0.2%
SYRESpyre Therapeutics, Inc.Sep 2026$0 USD——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —-12.2%+43.5%0.9%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.